...
首页> 外文期刊>Pharmacoepidemiology and drug safety >The Nordic prescription databases as a resource for pharmacoepidemiological research-a literature review.
【24h】

The Nordic prescription databases as a resource for pharmacoepidemiological research-a literature review.

机译:北欧处方数据库作为药物流行病学研究的资源-文献综述。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

All five Nordic countries have nationwide prescription databases covering all dispensed drugs, with potential for linkage to outcomes. The aim of this review is to present an overview of therapeutic areas studied and methods applied in pharmacoepidemiologic studies using data from these databases.The study consists of a Medline-based structured literature review of scientific papers published during 2005-2010 using data from the prescription databases in Denmark, Finland, Iceland, Norway, and Sweden, covering 25 million inhabitants. Relevant studies were analyzed in terms of pharmacological group, study population, outcomes examined, type of study (drug utilization vs. effect of drug therapy), country of origin, and extent of cross-national collaboration.A total of 515 studies were identified. Of these, 262 were conducted in Denmark, 97 in Finland, 4 in Iceland, 87 in Norway, and 61 in Sweden. Four studies used data from more than one Nordic country. The most commonly studied drugs were those acting on the nervous system, followed by cardiovascular drugs and gastrointestinal/endocrine drugs. A total of 228 studies examined drug utilization and 263 focused on the effects and safety of drug therapy. Pregnant women were the most commonly studied population in safety studies, whereas prescribers' adherence to guidelines was the most frequent topic of drug utilization studies.The Nordic prescription databases, with their possibility of record-linkage, represent an outstanding resource for assessing the beneficial and adverse effects of drug use in large populations, under routine care conditions, and with the potential for long-term follow-up. Copyright ? 2013 John Wiley & Sons, Ltd.
机译:北欧的所有五个国家/地区都拥有覆盖所有配药的全国性处方数据库,并有可能与结果挂钩。这篇综述的目的是使用这些数据库中的数据介绍治疗领域和药物流行病学研究方法的概述。该研究包括基于Medline的2005-2010年间用处方数据对科学论文进行结构化文献综述丹麦,芬兰,冰岛,挪威和瑞典的数据库,覆盖了2500万居民。根据药理学组别,研究人群,检查结果,研究类型(药物利用与药物治疗效果),来源国和跨国合作程度对相关研究进行了分析,共鉴定了515项研究。其中,在丹麦进行了262次,在芬兰进行了97次,在冰岛进行了4次,在挪威进行了87次,在瑞典进行了61次。四项研究使用了来自多个北欧国家的数据。研究最普遍的药物是作用于神经系统的药物,其次是心血管药物和胃肠道/内分泌药物。总共228项研究检查了药物使用情况,其中263项研究集中于药物治疗的效果和安全性。在安全性研究中,孕妇是最常研究的人群,而开药者遵循指南是药物利用研究中最常见的话题。北欧处方数据库及其可能的记录关联性,是评估有益和不良反应的重要资源。在常规护理条件下,在大量人群中吸毒的不良影响,并可能进行长期随访。版权? 2013 John Wiley&Sons,Ltd.

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号